State and territorial health departments have resumed distributing monoclonal antibodies to clinical sites, the Department of Health and Human Services announced yesterday. The federal government will determine how much weekly product states and territories receive based on new COVID-19 cases and hospitalizations and data on product inventory and use submitted to HHS Protect. Health departments will then distribute the product as they see fit, similar to the process used before sites began ordering the drugs directly from distributor AmerisourceBergen, HHS said. The change in distribution follows a surge in monoclonal antibody use due to the SARS-CoV-2 delta variant, particularly in areas of the country with low vaccination rates.

“Transitioning to a state/territory-coordinated distribution system gives health departments maximum flexibility to get these critical drugs where they are needed most,” HHS said. “…HHS will continue to monitor product utilization rates, COVID-19 case burden, and overall availability of monoclonal antibody therapeutics to determine when a shift back to the normal direct ordering process may be possible.”

For more information, email the Federal COVID-19 Response Team at COVID19therapeutics@hhs.gov
 

Related News Articles

Headline
Commenting on a forthcoming Centers for Medicare & Medicaid Services’ rule requiring COVID-19 vaccinations for workers in most health care settings…
Chairperson's File
On this episode, I discuss emergency preparedness, caregiver resiliency and health equity — all through the lens of the COVID-19 pandemic — with Fritz Francois…
Headline
The Centers for Medicare & Medicaid Services today announced that the agency will pay for Medicare beneficiaries’ booster doses, without cost sharing…
Headline
AHA today urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure…
Headline
The Centers for Disease Control and Prevention early Friday morning opted for a broad endorsement of Pfizer COVID-19 vaccine booster shots, issuing interim…
Headline
The AHA today urged the Health Resources and Services Administration to quickly distribute the $17 billion in Phase 4 provider relief funds and $8.5 billion in…